Canagliflozin as a Potential Preclinical Therapy for Tuberous Sclerosis Complex: Inhibition of Tsc2−/− Cell Proliferation via Cell Cycle Arrest and Mitochondrial Dysfunction

Ye J, Liu B, Wu J, Gao H, Wei Q, Su K, Zheng K, Dai X, Xu T, Wang Y, Liu S, Peng X, Gou L, Zhao Y, Xue B

Drug Design, Development and Therapy 2025, 19:10719-10733

Published Date: 4 December 2025